S2Medical AB (publ) (S2M.ST)
SEK 0.01
(4.55%)
SEK 0.01
(4.55%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -16.51 Million | -28.13 Million | -19.66 Million | -12.74 Million | -17.1 Million | -12.75 Million |
| Net Income | -15.26 Million | -27.68 Million | -19.83 Million | -15 Million | -18.43 Million | -10.73 Million |
| Depreciation & Amortization | 1.73 Million | 1.91 Million | 1.49 Million | 1.29 Million | 1.26 Million | 824.64 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 4.49 Million | -538.84 Thousand | -1.3 Million | 937.43 Thousand | 51.75 Thousand | -2.02 Million |
| Other non-cash items | -7.48 Million | -1.82 Million | -13.85 Thousand | 31.35 Thousand | 12.93 Thousand | -824.5 Thousand |
| Investing Cash Flow | 15.46 Million | -1.76 Million | -3.02 Million | -1.97 Million | -3.14 Million | -2.57 Million |
| Investments in PPE | -1.15 Million | -1.89 Million | -3.09 Million | -1.97 Million | -3.14 Million | -2.57 Million |
| Acquisitions | - | 137.61 Thousand | 72.5 Thousand | - | - | -1.00 |
| Investment purchases | - | - | - | - | - | -1.00 |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 15.46 Million | -1.65 Million | -2.83 Million | -1.91 Million | -2.5 Million | 1995.00 |
| Financing Cash Flow | 15.46 Million | 24.13 Million | 6.84 Million | 24.4 Million | -728.22 Thousand | 46.27 Million |
| Debt repayment | -1.82 Million | -207.69 Thousand | -623.07 Thousand | -678.22 Thousand | -728.22 Thousand | -630.62 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 21.99 Million | 22.51 Million | -2.52 Million | 26.17 Million | - | 51.33 Million |
| Other Financing Activities | -4.7 Million | 1.83 Million | 10 Million | -1.09 Million | -728.22 Thousand | -4.42 Million |
| Accounts receivables | -126.73 Thousand | 340.16 Thousand | -495.09 Thousand | 1.93 Million | -213.97 Thousand | -2.93 Million |
| Accounts payables | 3.39 Million | 888.38 Thousand | -719.83 Thousand | 1.01 Million | 790.17 Thousand | 2.36 Million |
| Inventory | 1.22 Million | -1.76 Million | -94.45 Thousand | -2.13 Million | -524.45 Thousand | -1.44 Million |
| Other working capital | 3.39 Million | 888.38 Thousand | -719.83 Thousand | 121.7 Thousand | 790.17 Thousand | -574.94 Thousand |
| Cash at beginning of period | 3.72 Million | 9.47 Million | 25.32 Million | 15.46 Million | 36.43 Million | 5.49 Million |
| Cash at end of period | 1.51 Million | 3.72 Million | 9.47 Million | 25.14 Million | 15.46 Million | 36.43 Million |
| Capital Expenditure | -1.15 Million | -1.89 Million | -3.09 Million | -1.97 Million | -3.14 Million | -2.57 Million |
| Effect of forex changes on cash | -913.00 | - | - | - | 1.00 | - |
| Net cash flow / Change in cash | -2.2 Million | -5.75 Million | -15.84 Million | 9.68 Million | -20.97 Million | 30.94 Million |
| Free Cash Flow | -17.67 Million | -30.03 Million | -22.76 Million | -14.72 Million | -20.24 Million | -15.32 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 6.95 Million | 804 Thousand | -22.7 Million | -3.82 Million | -6.06 Million | -5.12 Million |
| Depreciation & Amortization | 321 Thousand | 349 Thousand | 1.12 Million | 431 Thousand | 622 Thousand | 528 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -7 Million | -1.29 Million | 4.49 Million | 1.94 Million | 21.24 Million | -19.32 Million |
| Other non-cash items | 7.64 Million | 1.99 Million | -1.67 Million | -1.09 Million | -5000.00 | -3.17 Million |
| Investing Cash Flow | -422 Thousand | - | -1.15 Million | -330.95 Thousand | -389 Thousand | -298 Thousand |
| Investments in PPE | -422 Thousand | - | -1.15 Million | -330.95 Thousand | -389 Thousand | -298 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -422 Thousand | - | -1.15 Million | -330.95 Thousand | -389 Thousand | -298 Thousand |
| Financing Cash Flow | 164 Thousand | - | 15.46 Million | 1.81 Million | -15.58 Million | 27.77 Million |
| Debt repayment | -578 Thousand | - | -1.82 Million | -1.81 Million | -10.87 Million | -5.77 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -1001.00 | - | - |
| Common Stock Issuance | 742 Thousand | - | 17.29 Million | -4.7 Million | 1000.00 | 22 Million |
| Other Financing Activities | 742 Thousand | - | 17.29 Million | 237.00 | -10.87 Million | 11.55 Million |
| Accounts receivables | 880 Thousand | -800 Thousand | -126.73 Thousand | 978.26 Thousand | 22.04 Million | -23.66 Million |
| Accounts payables | -11.29 Million | -428 Thousand | 3.39 Million | -184.8 Thousand | -287 Thousand | 3.78 Million |
| Inventory | 3.41 Million | -66 Thousand | 1.22 Million | 1.14 Million | -505 Thousand | 566 Thousand |
| Other working capital | -11.29 Million | -428 Thousand | 3.39 Million | -184.8 Thousand | -287 Thousand | -1000.00 |
| Cash at beginning of period | 1.37 Million | 1.51 Million | 3.72 Million | 1.49 Million | 1.66 Million | 1.27 Million |
| Cash at end of period | 1.37 Million | 1.37 Million | 1.51 Million | 1.51 Million | 1.49 Million | 1.66 Million |
| Capital Expenditure | -422 Thousand | - | -1.15 Million | -330.95 Thousand | -389 Thousand | -298 Thousand |
| Effect of forex changes on cash | - | - | -913.00 | - | - | - |
| Net cash flow / Change in cash | -4000.00 | -141.02 Thousand | -2.2 Million | 20.02 Thousand | -165 Thousand | 391 Thousand |
| Free Cash Flow | -168 Thousand | -141 Thousand | -17.67 Million | -1.79 Million | 15.41 Million | -27.38 Million |
RKLB
9044
SDVKF
REC
LEN-B
RLLWF